Business Insider

FDA Grants Fast Track Designation to Merakris’ MTX-001, Opening Potential Accelerated Path to Market for Venous Leg Ulcer Therapy

RESEARCH TRIANGLE PARK, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Merakris Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to MTX-001, ...
Monthly Prescribing Reference

FDA Fast Tracks MTX-001 for Chronic Venous Leg Ulcer Treatment

Early findings suggest the biologic candidate improves wound closure and ulcer-related pain. The Food and Drug Administration (FDA) has granted Fast Track designation to MTX-001, an investigational ...
manilatimes

FDA Grants Fast Track Designation to Merakris’ MTX-001, Opening Potential Accelerated Path to Market for Venous Leg Ulcer Therapy

Fast Track Designation Provides Opportunities for Rolling BLA Review, Enhanced FDA Engagement, and Earlier Alignment on Manufacturing and Regulatory Requirements RESEARCH TRIANGLE PARK, N.C., June 02, ...